Cargando…
COVID-19: ICU delirium management during SARS-CoV-2 pandemic
The novel coronavirus, SARS-CoV-2-causing Coronavirus Disease 19 (COVID-19), emerged as a public health threat in December 2019 and was declared a pandemic by the World Health Organization in March 2020. Delirium, a dangerous untoward prognostic development, serves as a barometer of systemic injury...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186945/ https://www.ncbi.nlm.nih.gov/pubmed/32345343 http://dx.doi.org/10.1186/s13054-020-02882-x |
_version_ | 1783527063068606464 |
---|---|
author | Kotfis, Katarzyna Williams Roberson, Shawniqua Wilson, Jo Ellen Dabrowski, Wojciech Pun, Brenda T. Ely, E. Wesley |
author_facet | Kotfis, Katarzyna Williams Roberson, Shawniqua Wilson, Jo Ellen Dabrowski, Wojciech Pun, Brenda T. Ely, E. Wesley |
author_sort | Kotfis, Katarzyna |
collection | PubMed |
description | The novel coronavirus, SARS-CoV-2-causing Coronavirus Disease 19 (COVID-19), emerged as a public health threat in December 2019 and was declared a pandemic by the World Health Organization in March 2020. Delirium, a dangerous untoward prognostic development, serves as a barometer of systemic injury in critical illness. The early reports of 25% encephalopathy from China are likely a gross underestimation, which we know occurs whenever delirium is not monitored with a valid tool. Indeed, patients with COVID-19 are at accelerated risk for delirium due to at least seven factors including (1) direct central nervous system (CNS) invasion, (2) induction of CNS inflammatory mediators, (3) secondary effect of other organ system failure, (4) effect of sedative strategies, (5) prolonged mechanical ventilation time, (6) immobilization, and (7) other needed but unfortunate environmental factors including social isolation and quarantine without family. Given early insights into the pathobiology of the virus, as well as the emerging interventions utilized to treat the critically ill patients, delirium prevention and management will prove exceedingly challenging, especially in the intensive care unit (ICU). The main focus during the COVID-19 pandemic lies within organizational issues, i.e., lack of ventilators, shortage of personal protection equipment, resource allocation, prioritization of limited mechanical ventilation options, and end-of-life care. However, the standard of care for ICU patients, including delirium management, must remain the highest quality possible with an eye towards long-term survival and minimization of issues related to post-intensive care syndrome (PICS). This article discusses how ICU professionals (e.g., physicians, nurses, physiotherapists, pharmacologists) can use our knowledge and resources to limit the burden of delirium on patients by reducing modifiable risk factors despite the imposed heavy workload and difficult clinical challenges posed by the pandemic. |
format | Online Article Text |
id | pubmed-7186945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-71869452020-04-28 COVID-19: ICU delirium management during SARS-CoV-2 pandemic Kotfis, Katarzyna Williams Roberson, Shawniqua Wilson, Jo Ellen Dabrowski, Wojciech Pun, Brenda T. Ely, E. Wesley Crit Care Review The novel coronavirus, SARS-CoV-2-causing Coronavirus Disease 19 (COVID-19), emerged as a public health threat in December 2019 and was declared a pandemic by the World Health Organization in March 2020. Delirium, a dangerous untoward prognostic development, serves as a barometer of systemic injury in critical illness. The early reports of 25% encephalopathy from China are likely a gross underestimation, which we know occurs whenever delirium is not monitored with a valid tool. Indeed, patients with COVID-19 are at accelerated risk for delirium due to at least seven factors including (1) direct central nervous system (CNS) invasion, (2) induction of CNS inflammatory mediators, (3) secondary effect of other organ system failure, (4) effect of sedative strategies, (5) prolonged mechanical ventilation time, (6) immobilization, and (7) other needed but unfortunate environmental factors including social isolation and quarantine without family. Given early insights into the pathobiology of the virus, as well as the emerging interventions utilized to treat the critically ill patients, delirium prevention and management will prove exceedingly challenging, especially in the intensive care unit (ICU). The main focus during the COVID-19 pandemic lies within organizational issues, i.e., lack of ventilators, shortage of personal protection equipment, resource allocation, prioritization of limited mechanical ventilation options, and end-of-life care. However, the standard of care for ICU patients, including delirium management, must remain the highest quality possible with an eye towards long-term survival and minimization of issues related to post-intensive care syndrome (PICS). This article discusses how ICU professionals (e.g., physicians, nurses, physiotherapists, pharmacologists) can use our knowledge and resources to limit the burden of delirium on patients by reducing modifiable risk factors despite the imposed heavy workload and difficult clinical challenges posed by the pandemic. BioMed Central 2020-04-28 /pmc/articles/PMC7186945/ /pubmed/32345343 http://dx.doi.org/10.1186/s13054-020-02882-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Kotfis, Katarzyna Williams Roberson, Shawniqua Wilson, Jo Ellen Dabrowski, Wojciech Pun, Brenda T. Ely, E. Wesley COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
title | COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
title_full | COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
title_fullStr | COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
title_full_unstemmed | COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
title_short | COVID-19: ICU delirium management during SARS-CoV-2 pandemic |
title_sort | covid-19: icu delirium management during sars-cov-2 pandemic |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186945/ https://www.ncbi.nlm.nih.gov/pubmed/32345343 http://dx.doi.org/10.1186/s13054-020-02882-x |
work_keys_str_mv | AT kotfiskatarzyna covid19icudeliriummanagementduringsarscov2pandemic AT williamsrobersonshawniqua covid19icudeliriummanagementduringsarscov2pandemic AT wilsonjoellen covid19icudeliriummanagementduringsarscov2pandemic AT dabrowskiwojciech covid19icudeliriummanagementduringsarscov2pandemic AT punbrendat covid19icudeliriummanagementduringsarscov2pandemic AT elyewesley covid19icudeliriummanagementduringsarscov2pandemic |